Hikma Slashes Generics Forecast After Key Product Delay

Expected US Launch Of Authorized Generic Xyrem Slips To As Late As 2023

 
• By David Wallace
Cut Dollars Slash Sales Forecast
Hikma has cut its generics sales expectations • Source: Maren Winter / Alamy Stock Photo

More from Generics

More from Products